{"altmetric_id":1517389,"counts":{"readers":{"citeulike":"0","mendeley":"29","connotea":"0"},"facebook":{"unique_users_count":1,"unique_users":["17672546419"],"posts_count":1},"news":{"unique_users_count":6,"unique_users":["chemistryviews","upi_com","ecancer","eurekalert","medicalxpress","webmd_news"],"posts_count":6},"total":{"posts_count":12},"twitter":{"unique_users_count":4,"unique_users":["NatRevClinOncol","Cancer_Commons","prostatecancer_","aftimosp"],"posts_count":4},"wikipedia":{"unique_users_count":1,"unique_users":["en:5551810"],"posts_count":1},"downloads":{"publisher":{"views_granted_access":5179,"timeline":{"2013-05-28":120,"2013-05-29":242,"2013-05-30":299,"2013-05-31":161,"2013-06-01":26,"2013-06-02":42,"2013-06-03":281,"2013-06-04":97,"2013-06-05":77,"2013-06-06":29,"2013-06-07":37,"2013-06-08":1,"2013-06-09":6,"2013-06-10":29,"2013-06-11":15,"2013-06-12":71,"2013-06-13":32,"2013-06-14":10,"2013-06-15":10,"2013-06-16":1,"2013-06-17":37,"2013-06-18":34,"2013-06-19":15,"2013-06-20":17,"2013-06-21":27,"2013-06-22":1,"2013-06-23":3,"2013-06-24":9,"2013-06-25":30,"2013-06-26":14,"2013-06-27":14,"2013-06-28":21,"2013-06-29":2,"2013-06-30":6,"2013-07-01":19,"2013-07-02":11,"2013-07-03":15,"2013-07-04":10,"2013-07-05":3,"2013-07-08":7,"2013-07-09":7,"2013-07-10":26,"2013-07-11":19,"2013-07-12":6,"2013-07-15":12,"2013-07-16":18,"2013-07-17":8,"2013-07-18":16,"2013-07-19":6,"2013-07-20":7,"2013-07-22":16,"2013-07-23":34,"2013-07-24":19,"2013-07-25":6,"2013-07-26":12,"2013-07-30":7,"2013-07-31":15,"2013-08-01":43,"2013-08-02":25,"2013-08-04":6,"2013-08-05":13,"2013-08-06":20,"2013-08-07":11,"2013-08-08":11,"2013-08-09":15,"2013-08-11":10,"2013-08-12":41,"2013-08-13":19,"2013-08-14":5,"2013-08-15":14,"2013-08-16":20,"2013-08-17":4,"2013-08-18":6,"2013-08-19":28,"2013-08-20":17,"2013-08-21":19,"2013-08-22":12,"2013-08-23":4,"2013-08-24":3,"2013-08-26":5,"2013-08-27":4,"2013-08-28":26,"2013-08-29":6,"2013-08-30":1,"2013-09-01":4,"2013-09-02":15,"2013-09-03":4,"2013-09-04":12,"2013-09-05":4,"2013-09-06":15,"2013-09-07":1,"2013-09-09":5,"2013-09-10":5,"2013-09-11":5,"2013-09-13":3,"2013-09-14":6,"2013-09-15":2,"2013-09-16":4,"2013-09-17":1,"2013-09-18":2,"2013-09-19":5,"2013-09-20":3,"2013-09-23":6,"2013-09-24":6,"2013-09-25":5,"2013-09-26":1,"2013-09-27":1,"2013-09-30":4,"2013-10-01":4,"2013-10-02":2,"2013-10-03":2,"2013-10-04":1,"2013-10-05":4,"2013-10-06":1,"2013-10-07":9,"2013-10-08":5,"2013-10-09":1,"2013-10-10":6,"2013-10-11":7,"2013-10-14":1,"2013-10-15":5,"2013-10-16":4,"2013-10-17":2,"2013-10-18":3,"2013-10-20":77,"2013-10-21":5,"2013-10-22":3,"2013-10-23":5,"2013-10-24":9,"2013-10-25":3,"2013-10-26":1,"2013-10-27":8,"2013-10-28":4,"2013-10-29":9,"2013-10-30":1,"2013-10-31":1,"2013-11-01":5,"2013-11-03":1,"2013-11-04":2,"2013-11-05":2,"2013-11-06":3,"2013-11-07":5,"2013-11-08":1,"2013-11-10":1,"2013-11-12":2,"2013-11-13":11,"2013-11-14":11,"2013-11-15":9,"2013-11-16":4,"2013-11-17":4,"2013-11-18":10,"2013-11-19":10,"2013-11-20":9,"2013-11-21":5,"2013-11-22":5,"2013-11-23":3,"2013-11-25":18,"2013-11-26":4,"2013-11-27":10,"2013-11-28":1,"2013-11-29":1,"2013-11-30":2,"2013-12-01":3,"2013-12-02":9,"2013-12-03":7,"2013-12-04":9,"2013-12-05":4,"2013-12-06":5,"2013-12-07":2,"2013-12-08":3,"2013-12-09":4,"2013-12-10":2,"2013-12-11":6,"2013-12-12":5,"2013-12-13":5,"2013-12-14":1,"2013-12-15":2,"2013-12-16":7,"2013-12-17":4,"2013-12-18":3,"2013-12-20":1,"2013-12-22":1,"2013-12-23":3,"2013-12-25":1,"2013-12-30":1,"2013-12-31":3,"2014-01-01":3,"2014-01-02":11,"2014-01-03":5,"2014-01-04":1,"2014-01-05":3,"2014-01-06":14,"2014-01-07":7,"2014-01-08":15,"2014-01-09":4,"2014-01-10":3,"2014-01-12":5,"2014-01-13":15,"2014-01-14":16,"2014-01-15":4,"2014-01-16":5,"2014-01-17":7,"2014-01-18":7,"2014-01-19":4,"2014-01-20":8,"2014-01-21":3,"2014-01-22":1,"2014-01-23":4,"2014-01-24":9,"2014-01-25":1,"2014-01-26":6,"2014-01-27":3,"2014-01-28":2,"2014-01-29":1,"2014-01-30":2,"2014-02-03":5,"2014-02-04":1,"2014-02-05":3,"2014-02-06":8,"2014-02-07":1,"2014-02-10":1,"2014-02-11":9,"2014-02-12":1,"2014-02-13":3,"2014-02-14":1,"2014-02-16":2,"2014-02-17":3,"2014-02-18":3,"2014-02-19":2,"2014-02-20":1,"2014-02-21":2,"2014-02-22":1,"2014-02-24":6,"2014-02-25":2,"2014-02-26":3,"2014-02-27":2,"2014-02-28":2,"2014-03-02":1,"2014-03-04":3,"2014-03-05":2,"2014-03-07":3,"2014-03-11":2,"2014-03-12":1,"2014-03-17":7,"2014-03-18":1,"2014-03-19":3,"2014-03-20":6,"2014-03-21":3,"2014-03-22":2,"2014-03-23":1,"2014-03-24":1,"2014-03-25":4,"2014-03-26":3,"2014-03-28":2,"2014-03-31":5,"2014-04-01":7,"2014-04-02":4,"2014-04-03":1,"2014-04-04":6,"2014-04-07":5,"2014-04-08":2,"2014-04-09":3,"2014-04-14":2,"2014-04-15":1,"2014-04-16":1,"2014-04-17":4,"2014-04-18":1,"2014-04-22":7,"2014-04-23":6,"2014-04-29":7,"2014-04-30":1,"2014-05-01":1,"2014-05-02":1,"2014-05-03":2,"2014-05-05":2,"2014-05-06":4,"2014-05-08":6,"2014-05-10":1,"2014-05-12":2,"2014-05-15":17,"2014-05-16":2,"2014-05-19":4,"2014-05-20":4,"2014-05-21":8,"2014-05-22":10,"2014-05-24":3,"2014-05-25":4,"2014-05-26":4,"2014-05-28":2,"2014-06-03":4,"2014-06-04":4,"2014-06-05":4,"2014-06-08":2,"2014-06-09":3,"2014-06-11":6,"2014-06-12":2,"2014-06-13":3,"2014-06-16":2,"2014-06-17":3,"2014-06-18":3,"2014-06-19":5,"2014-06-23":5,"2014-06-25":3,"2014-06-26":1,"2014-06-27":1,"2014-06-30":2,"2014-07-02":10,"2014-07-03":3,"2014-07-06":4,"2014-07-07":2,"2014-07-08":1,"2014-07-09":1,"2014-07-10":3,"2014-07-12":1,"2014-07-14":2,"2014-07-15":3,"2014-07-16":2,"2014-07-17":2,"2014-07-18":2,"2014-07-20":1,"2014-07-21":2,"2014-07-22":5,"2014-07-23":6,"2014-07-24":1,"2014-07-25":1,"2014-07-28":3,"2014-07-30":4,"2014-08-01":2,"2014-08-04":3,"2014-08-05":3,"2014-08-08":1,"2014-08-11":1,"2014-08-13":1,"2014-08-14":4,"2014-08-15":1,"2014-08-16":2,"2014-08-18":7,"2014-08-19":4,"2014-08-21":1,"2014-08-22":3,"2014-08-25":5,"2014-08-26":7,"2014-08-27":4,"2014-08-28":3,"2014-08-29":1,"2014-08-30":1,"2014-09-03":2,"2014-09-04":5,"2014-09-06":2,"2014-09-08":3,"2014-09-09":14,"2014-09-10":3,"2014-09-11":4,"2014-09-12":2,"2014-09-13":1,"2014-09-14":1,"2014-09-17":1,"2014-09-18":3,"2014-09-19":2,"2014-09-22":5,"2014-09-23":4,"2014-09-24":3,"2014-09-25":3,"2014-09-26":1,"2014-09-28":1,"2014-09-29":6,"2014-09-30":4,"2014-10-02":4,"2014-10-03":7,"2014-10-05":3,"2014-10-06":3,"2014-10-07":3,"2014-10-08":7,"2014-10-09":2,"2014-10-10":2,"2014-10-11":2,"2014-10-12":3,"2014-10-13":5,"2014-10-15":9,"2014-10-17":1,"2014-10-18":3,"2014-10-19":1,"2014-10-20":6,"2014-10-21":1,"2014-10-22":4,"2014-10-23":3,"2014-10-24":2,"2014-10-26":4,"2014-10-27":13,"2014-10-28":3,"2014-10-29":3,"2014-10-30":5,"2014-10-31":3,"2014-11-01":5,"2014-11-02":1,"2014-11-04":5,"2014-11-05":2,"2014-11-06":12,"2014-11-07":3,"2014-11-10":5,"2014-11-11":1,"2014-11-12":5,"2014-11-13":2,"2014-11-14":5,"2014-11-15":1,"2014-11-16":1,"2014-11-17":5,"2014-11-18":2,"2014-11-19":5,"2014-11-20":2,"2014-11-21":3,"2014-11-24":7,"2014-11-25":3,"2014-11-26":4,"2014-11-27":5,"2014-11-28":8,"2014-12-02":1,"2014-12-03":1,"2014-12-04":6,"2014-12-06":2,"2014-12-08":1,"2014-12-10":2,"2014-12-11":3,"2014-12-13":1,"2014-12-14":3,"2014-12-15":4,"2014-12-16":3,"2014-12-18":1,"2014-12-20":2,"2014-12-21":2,"2014-12-22":4,"2014-12-23":2,"2014-12-26":1,"2014-12-27":2,"2014-12-29":2,"2015-01-01":3,"2015-01-05":3,"2015-01-06":9,"2015-01-12":2,"2015-01-13":1,"2015-01-14":6,"2015-01-15":4,"2015-01-20":4,"2015-01-21":6,"2015-01-23":5,"2015-01-24":1,"2015-01-26":1,"2015-01-28":2,"2015-01-29":1,"2015-01-30":1,"2015-01-31":2,"2015-02-02":3,"2015-02-03":3,"2015-02-05":3,"2015-02-06":3,"2015-02-11":1,"2015-02-12":4,"2015-02-13":1,"2015-02-16":8,"2015-02-17":6,"2015-02-18":2,"2015-02-19":1,"2015-02-20":1,"2015-02-22":1,"2015-02-26":4,"2015-02-27":1,"2015-03-01":3,"2015-03-02":3,"2015-03-03":2,"2015-03-04":1,"2015-03-05":2,"2015-03-06":2,"2015-03-08":1,"2015-03-09":1,"2015-03-10":1,"2015-03-11":1,"2015-03-12":1,"2015-03-13":1,"2015-03-14":1,"2015-03-16":2,"2015-03-17":2,"2015-03-18":4,"2015-03-19":3,"2015-03-20":6,"2015-03-21":1,"2015-03-23":9,"2015-03-24":9,"2015-03-25":18,"2015-03-26":4,"2015-03-27":9,"2015-03-29":2,"2015-03-30":1,"2015-04-01":5,"2015-04-02":12,"2015-04-03":1,"2015-04-04":3,"2015-04-06":4,"2015-04-07":2,"2015-04-13":1,"2015-04-18":1,"2015-04-20":3,"2015-04-21":1,"2015-04-23":1,"2015-04-24":1,"2015-04-27":8,"2015-04-29":1,"2015-04-30":3,"2015-05-04":3,"2015-05-05":1,"2015-05-06":3,"2015-05-11":2,"2015-05-18":1,"2015-05-19":1,"2015-05-20":4,"2015-05-21":3,"2015-05-22":5,"2015-05-23":1,"2015-05-28":1,"2015-05-29":4,"2015-06-03":6,"2015-06-04":4,"2015-06-06":2,"2015-06-07":2,"2015-06-09":7,"2015-06-10":2,"2015-06-11":4,"2015-06-12":1,"2015-06-15":2,"2015-06-16":3,"2015-06-19":5,"2015-06-22":4,"2015-06-23":4,"2015-06-24":2,"2015-06-26":1,"2015-06-29":1,"2015-06-30":1,"2015-07-01":1,"2015-07-02":2,"2015-07-03":1,"2015-07-05":1,"2015-07-06":6,"2015-07-09":4,"2015-07-10":1,"2015-07-13":3,"2015-07-16":3,"2015-07-18":2,"2015-07-20":5,"2015-07-21":5,"2015-07-22":2,"2015-07-23":3,"2015-07-24":5,"2015-07-25":1,"2015-07-27":10,"2015-07-28":1,"2015-07-29":1,"2015-07-31":2,"2015-08-01":3,"2015-08-02":1,"2015-08-06":2,"2015-08-10":1,"2015-08-12":13,"2015-08-14":4,"2015-08-17":2,"2015-08-21":1,"2015-08-24":5,"2015-08-25":3,"2015-08-26":4,"2015-08-27":4,"2015-08-28":4,"2015-08-30":2,"2015-09-01":3,"2015-09-02":1,"2015-09-03":2,"2015-09-06":5,"2015-09-08":6,"2015-09-09":2,"2015-09-16":3,"2015-09-18":1,"2015-09-21":1,"2015-09-22":2,"2015-09-23":3,"2015-09-24":4,"2015-09-25":1,"2015-09-27":5,"2015-09-28":8,"2015-09-29":4,"2015-10-01":9,"2015-10-02":2,"2015-10-05":2,"2015-10-06":2,"2015-10-07":1,"2015-10-09":4,"2015-10-12":10,"2015-10-14":3,"2015-10-15":3,"2015-10-19":2,"2015-10-20":2,"2015-10-21":2,"2015-10-22":1,"2015-10-23":2,"2015-10-25":3,"2015-10-26":1,"2015-11-03":3,"2015-11-05":4,"2015-11-06":2,"2015-11-07":1,"2015-11-09":4,"2015-11-10":4,"2015-11-11":3,"2015-11-13":3,"2015-11-16":9,"2015-11-17":4,"2015-11-20":2,"2015-11-21":1,"2015-11-24":1,"2015-11-25":2,"2015-11-29":2,"2015-11-30":6,"2015-12-01":2,"2015-12-06":6,"2015-12-07":2,"2015-12-08":1,"2015-12-09":1,"2015-12-10":1,"2015-12-11":4,"2015-12-17":6,"2015-12-22":1,"2015-12-27":1,"2015-12-28":1,"2015-12-31":1,"2016-01-04":2,"2016-01-05":6,"2016-01-06":3,"2016-01-07":3,"2016-01-11":3,"2016-01-12":3,"2016-01-13":3,"2016-01-15":3,"2016-01-17":1,"2016-01-18":3,"2016-01-19":7,"2016-01-21":2,"2016-01-22":9,"2016-01-23":1,"2016-01-25":14,"2016-01-26":4,"2016-01-27":7,"2016-01-28":1,"2016-02-02":8,"2016-02-04":2,"2016-02-05":16,"2016-02-08":1,"2016-02-09":5,"2016-02-10":4,"2016-02-11":12,"2016-02-12":3,"2016-02-15":6,"2016-02-16":1,"2016-02-17":4,"2016-02-18":2,"2016-02-19":7,"2016-02-21":1,"2016-02-22":1,"2016-02-23":7,"2016-02-25":4,"2016-02-26":1,"2016-02-27":3,"2016-02-28":2,"2016-02-29":3,"2016-03-01":5,"2016-03-02":2,"2016-03-03":6,"2016-03-04":2,"2016-03-05":2,"2016-03-08":6,"2016-03-09":3,"2016-03-10":2,"2016-03-11":1,"2016-03-14":3,"2016-03-15":3,"2016-03-16":8,"2016-03-18":1,"2016-03-21":1,"2016-03-22":2,"2016-03-23":8,"2016-03-25":5,"2016-03-26":1,"2016-03-27":1,"2016-03-28":6,"2016-03-29":2,"2016-03-30":3,"2016-03-31":5,"2016-04-02":2,"2016-04-04":1,"2016-04-05":2,"2016-04-06":2,"2016-04-07":1,"2016-04-10":3,"2016-04-11":3,"2016-04-12":4,"2016-04-13":2,"2016-04-14":3,"2016-04-15":2,"2016-04-17":2,"2016-04-18":22,"2016-04-19":3,"2016-04-21":3,"2016-04-22":7,"2016-04-24":2,"2016-04-25":11,"2016-04-26":1,"2016-04-28":2,"2016-04-29":2,"2016-05-01":1,"2016-05-02":11,"2016-05-03":5,"2016-05-04":3,"2016-05-05":2,"2016-05-06":2,"2016-05-08":134,"2016-05-09":1,"2016-05-10":6,"2016-05-13":4,"2016-05-15":1,"2016-05-16":2,"2016-05-18":1,"2016-05-19":1,"2016-05-20":1,"2016-05-21":1,"2016-05-24":2,"2016-05-25":1,"2016-05-26":2,"2016-05-27":5,"2016-05-29":7,"2016-05-31":6,"2016-06-01":1,"2016-06-02":7,"2016-06-03":6,"2016-06-05":3,"2016-06-06":2,"2016-06-07":8,"2016-06-08":3,"2016-06-11":1,"2016-06-13":1,"2016-06-14":2,"2016-06-15":11,"2016-06-17":3,"2016-06-18":1,"2016-06-20":14,"2016-06-21":1,"2016-06-22":3,"2016-06-23":3,"2016-06-24":2,"2016-06-25":2,"2016-06-26":5,"2016-06-27":4,"2016-06-28":3,"2016-06-29":3,"2016-06-30":5,"2016-07-01":3,"2016-07-07":1,"2016-07-08":3,"2016-07-11":6,"2016-07-12":3,"2016-07-14":2,"2016-07-19":2,"2016-07-20":1,"2016-07-21":1,"2016-07-23":1,"2016-07-25":4,"2016-07-27":3,"2016-07-28":2,"2016-08-02":1,"2016-08-03":3,"2016-08-04":2,"2016-08-05":2}}}},"citation":{"abstract":"The growth of advanced prostate cancer depends on androgen receptor signalling, however treatment options are limited. Here we report the disruption of specific protein-protein interactions involving LXXLL motifs in androgen receptor-coregulator proteins such as PELP1 using a novel, small molecule peptidomimetic (D2). D2 is stable, non-toxic and efficiently taken up by prostate cancer cells. Importantly, D2 blocks androgen-induced nuclear uptake and genomic activity of the androgen receptor. Furthermore, D2 abrogates androgen-induced proliferation of prostate cancer cells in vitro with an IC50 of 40 nM, and inhibits tumour growth in a mouse xenograft model. D2 also disrupts androgen receptor-coregulator interactions in ex vivo cultures of primary human prostate tumours. These findings provide evidence that targeting androgen receptor-coregulator interactions using peptidomimetics may be a viable therapeutic approach for patients with advanced prostate cancer.","altmetric_jid":"4f6fa62f3cf058f610008259","authors":["Preethi Ravindranathan","Tae-Kyung Lee","Lin Yang","Margaret M. Centenera","Lisa Butler","Wayne D. Tilley","Jer-Tsong Hsieh","Jung-Mo Ahn","Ganesh V. Raj"],"doi":"10.1038/ncomms2912","endpage":"","first_seen_on":"2013-05-29T11:45:24+00:00","issns":["2041-1733","2041-1723"],"journal":"Nature Communications","links":["http://www.nature.com/ncomms/journal/v4/n5/full/ncomms2912.html","http://www.ncbi.nlm.nih.gov/pubmed/23715282","http://dx.doi.org/10.1038/ncomms2912","http://www.ncbi.nlm.nih.gov/pubmed/23715282|journal = Nature Communications"],"pmid":"23715282","pubdate":"2013-05-28T00:00:00+00:00","publisher":"Nature Publishing Group","publisher_subjects":[{"name":"Multidisciplinary","scheme":"era"}],"startpage":"1923","subjects":["biology","science"],"title":"Peptidomimetic targeting of critical androgen receptor-coregulator interactions in prostate cancer.","type":"article","volume":"4","mendeley_url":"http://www.mendeley.com/research/peptidomimetic-targeting-critical-androgen-receptorcoregulator-interactions-prostate-cancer"},"altmetric_score":{"score":55.5,"score_history":{"1y":3,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":55.5},"context_for_score":{"all":{"total_number_of_other_articles":5098140,"mean":6.0409441535438,"rank":85230,"this_scored_higher_than_pct":98,"this_scored_higher_than":5012839,"rank_type":"exact","sample_size":5098140,"percentile":98},"similar_age_3m":{"total_number_of_other_articles":94790,"mean":7.2658671153826,"rank":2240,"this_scored_higher_than_pct":97,"this_scored_higher_than":92549,"rank_type":"exact","sample_size":94790,"percentile":97},"this_journal":{"total_number_of_other_articles":8339,"mean":33.924196449988,"rank":1483,"this_scored_higher_than_pct":82,"this_scored_higher_than":6855,"rank_type":"exact","sample_size":8339,"percentile":82},"similar_age_this_journal_3m":{"total_number_of_other_articles":316,"mean":23.677320634921,"rank":38,"this_scored_higher_than_pct":87,"this_scored_higher_than":278,"rank_type":"exact","sample_size":316,"percentile":87}}},"demographics":{"poster_types":{"member_of_the_public":2,"practitioner":1,"science_communicator":1},"users":{"twitter":{"cohorts":{"Science communicators (journalists, bloggers, editors)":1,"Members of the public":2,"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Researcher":8,"Professor > Associate Professor":2,"Student  > Master":4,"Professor":4,"Student  > Ph. D. Student":8,"Student  > Doctoral Student":3},"by_discipline":{"Medicine and Dentistry":4,"Chemistry":9,"Agricultural and Biological Sciences":16}}},"geo":{"twitter":{"GB":1,"US":1,"BE":1},"mendeley":{"GB":1,"IN":1}}},"posts":{"facebook":[{"url":"https://www.facebook.com/permalink.php?story_fbid=10151680737376420&id=17672546419","posted_on":"2013-05-31T13:26:45+00:00","license":"public","citation_ids":[1517389],"summary":"New prostate cancer treatment overcomes drug resistance.\r\n\r\nProstate cancer cells often rely on hormones like testosterone to grow.  Treatments designed to block the process typically work for a while and then the cancers become resistant to the treatments","author":{"name":"CancerQuest","url":"https://www.facebook.com/17672546419","facebook_wall_name":"CancerQuest","image":"https://graph.facebook.com/17672546419/picture","id_on_source":"17672546419"}}],"news":[{"title":"Preventing Dangerous Liaisons","url":"http://www.chemistryviews.org/details/news/4884471/Preventing_Dangerous_Liaisons.html","posted_on":"2013-06-18T02:07:00+00:00","license":"public","citation_ids":[1517389],"summary":"","author":{"name":"ChemistryViews","url":"http://www.chemistryviews.org/","image":"https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/074/normal/image.png?1369859403"}},{"title":"Class of drugs interrupts prostate cancer signaling","url":"http://www.upi.com/Health_News/2013/05/30/Class-of-drugs-interrupts-prostate-cancer-signaling/UPI-88391369892029/","posted_on":"2013-05-30T05:33:49+00:00","license":"public","citation_ids":[1517389],"summary":"DALLAS, May 30 (UPI) -- A novel class of drugs interrupts critical signaling needed for prostate cancer cells to grow, U.S. researchers say.","author":{"name":"UPI.com","url":"http://upi.com/","image":"https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/057/normal/upi_com.png?1369846942"}},{"title":"Researchers identify novel class of drugs for prostate cancers","url":"http://ecancer.org/news/4103-researchers-identify-novel-class-of-drugs-for-prostate-cancers.php","posted_on":"2013-05-29T09:14:00+00:00","license":"public","citation_ids":[1517389],"summary":"A new study on prostate cancer describes a novel class of drugs developed by UT Southwestern Medical Center researchers that interrupts critical signaling needed for prostate cancer cells to grow. In men with advanced prostate cancer, growth of cancer...","author":{"name":"ecancer","url":"http://ecancer.org/","image":"https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/075/normal/image.png?1369859451"}},{"title":"Small molecule could have big impact on cancer","url":"http://www.eurekalert.org/pub_releases/2013-05/uota-smc052813.php","posted_on":"2013-05-28T04:00:00+00:00","license":"public","citation_ids":[1517389],"summary":"( University of Texas at Dallas ) Dr. Jung-Mo Ahn, associate professor of chemistry at The University of Texas at Dallas, has designed and synthesized a novel small molecule that might become a large weapon in the fight against prostate cancer. In a study","author":{"name":"EurekAlert!","url":"http://www.eurekalert.org/","image":"https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/077/normal/image.png?1369859505"}},{"title":"Small molecule could have big impact on cancer","url":"http://medicalxpress.com/news/2013-05-small-molecule-big-impact-cancer.html","posted_on":"2013-05-28T21:18:04+00:00","license":"public","citation_ids":[1517389],"summary":"","author":{"name":"MedicalXpress","url":"http://medicalxpress.com/","image":"https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/152/normal/image.png?1369925783"}},{"title":"Experimental Drugs Show Promise Against Prostate Cancer","url":"http://www.webmd.com/prostate-cancer/news/20130531/experimental-drugs-show-promise-against-prostate-cancer","posted_on":"2013-05-31T15:32:24+00:00","license":"public","citation_ids":[1517389],"summary":"Tumor growth suppressed in lab tests; human trials still needed, study authors say","author":{"name":"WebMD News","url":"http://www.webmd.com/","image":"https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/049/normal/image.png?1369859983"}}],"twitter":[{"url":"http://twitter.com/NatRevClinOncol/statuses/339713610253217792","posted_on":"2013-05-29T12:03:30+00:00","license":"public","citation_ids":[1517389],"author":{"name":"NatureRevClinOncol","url":"http://www.nature.com/nrclinonc/index.html","image":"https://pbs.twimg.com/profile_images/1587954262/nrclinonc_Twitter_logo_normal.jpg","description":"The latest clinical diagnostic, treatment & personalized medicine advances & more from Nature Reviews Clinical Oncology, a reviews journal. Tweets by the eds.","id_on_source":"NatRevClinOncol","tweeter_id":"347276297","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":6699},"tweet_id":"339713610253217792"},{"url":"http://twitter.com/Cancer_Commons/statuses/340506810198929409","posted_on":"2013-05-31T16:35:24+00:00","license":"public","citation_ids":[1517389],"author":{"name":"Cancer Commons","url":"http://www.cancercommons.org/","image":"https://pbs.twimg.com/profile_images/378800000116423487/634c2e55edaf03c27523f83a2951a964_normal.png","description":"A nonprofit giving patients the information they need. Ask your question: https://platform.cancercommons.org/ask/","id_on_source":"Cancer_Commons","tweeter_id":"627934074","geo":{"lt":37.44188,"ln":-122.14302,"country":"US"},"followers":1663},"tweet_id":"340506810198929409"},{"url":"http://twitter.com/prostatecancer_/statuses/341502670810542080","posted_on":"2013-06-03T10:32:36+00:00","license":"public","citation_ids":[1517389],"author":{"name":"Prostate Cancer","url":"http://t.co/2Xybvvx8WT","image":"http://a0.twimg.com/profile_images/487011522/7._Colon_Cancer_normal.jpg","description":"You just hit the official Twitter Page of Prostate Cancer Community!  We have the info you need when it come to Prostate Cancer.  Dive in and get connected!","id_on_source":"prostatecancer_","tweeter_id":"84735932","followers":4145},"tweet_id":"341502670810542080"},{"url":"http://twitter.com/aftimosp/statuses/340864450338885635","posted_on":"2013-06-01T16:16:32+00:00","license":"public","citation_ids":[1517389],"author":{"name":"Philippe Aftimos, MD","url":"http://be.linkedin.com/pub/philippe-aftimos-md/25/a76/664","image":"https://pbs.twimg.com/profile_images/712249367340650497/vC1FNNXg_normal.jpg","description":"Hematologist & Medical Oncologist, Therapeutic Innovation leader of the Clinical Pharmacology Unit @ Institut Jules Bordet, Brussels. Views are my own.","id_on_source":"aftimosp","tweeter_id":"177176270","geo":{"lt":50.85045,"ln":4.34878,"country":"BE"},"followers":1854},"tweet_id":"340864450338885635"}],"wikipedia":[{"title":"PELP-1","url":"http://en.wikipedia.org/?diff=prev&oldid=690703660#altmetric_citation_f8742df5-b4f1-4f54-a407-61e4c5e9bea8","posted_on":"2015-11-15T02:51:35+00:00","license":"public","citation_ids":[1517389],"summary":"PELP1 has a histone binding domain and interacts with chromatin-modifying complexes, including CBP/p300, histone deacetylase 2, histones,  Sumo-2, lysine-specific demethylase 1 (KDM1), PRMT6, CARM1.   PELP1 also  interacts with cell cycle regulators such a","page_url":"http://en.wikipedia.org/?curid=5551810","wiki_lang":"en","author":{"name":"Ratnavadlamudi","url":"http://en.wikipedia.org/wiki/User:Ratnavadlamudi"}}]},"score":55.5,"images":{"small":"https://altmetric-badges.a.ssl.fastly.net/?size=64&score=56&types=mmmmttwf","medium":"https://altmetric-badges.a.ssl.fastly.net/?size=100&score=56&types=mmmmttwf","large":"https://altmetric-badges.a.ssl.fastly.net/?size=180&score=56&types=mmmmttwf"}}